Почетна › Рак простате › Тексас › Fort Worth

Kliničke studije za Рак простате u gradu Fort Worth, TX

10 studija za Рак простате traži učesnike na lokacijama u gradu Fort Worth i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Тражи се учесникФаза 3

Tarrant County Hospital District/JPS Health Network, Fort Worth
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth

Узраст 18 и старији · Мушкарци · Ажурирано 13. 11. 2026. · NCT04423211

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Тражи се учесникФаза 2

UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03866382

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Тражи се учесникФаза 2

UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth

Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06632977

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Тражи се учесникФаза 3

Urology Partners of North Texas (UPNT), Fort Worth

Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT07723248

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Тражи се учесникФаза 3

UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth

Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT06931340

Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

Тражи се учесникФаза 3

Research Site, Fort Worth

Узраст 18 и старији · Мушкарци · Ажурирано 15. 10. 2026. · NCT07711002

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Тражи се учесникФаза 3

University of Texas Southwestern Simmons Cancer Center - Fort Worth, Fort Worth

Узраст 18 и старији · Мушкарци · Ажурирано 14. 10. 2026. · NCT07028853

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Тражи се учесникФаза 3

UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth

Узраст 18 и старији · Мушкарци · Ажурирано 8. 10. 2026. · NCT03678025

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

Тражи се учесникФаза 1

START Dallas-Fort Worth, Fort Worth

Узраст 18 и старији · Мушкарци · Ажурирано 24. 9. 2026. · NCT07719361

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Тражи се учесникФаза 1

START Dallas, Fort Worth

Узраст 18 и старији · Оба пола · Ажурирано 10. 6. 2026. · NCT07517198

Studije za Рак простате u drugim gradovima

Ostale studije u gradu Fort Worth

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.